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Background: Activation of the PI3K/Akt pathway mediates crucial cellular functions regulated by receptor tyrosine
kinases, such as cell growth, proliferation, survival and metabolism. Previously, we reported that the whole-body
knockout of the Src homology domain-containing adaptor protein Nck1 improves overall glucose homeostasis and
insulin-induced activation of the PI3K/Akt pathway in liver of obese mice. The aim of the current study is to
elucidate the mechanism by which Nck1 depletion regulates hepatic insulin signaling.
Results: Here, we demonstrate that Nck1 regulates the activation of the PI3K/Akt pathway in a protein tyrosine
phosphatase 1B (PTP1B)-dependent mechanism. Indeed, depletion of Nck1 by siRNA in HepG2 cells enhances
PI3K-dependent basal and growth factor-induced Akt activation. In accordance, primary hepatocytes isolated from
Nck1−/− mice also display enhanced Akt activation in response to insulin. Activation of the PI3K/Akt pathway in
Nck1-depleted HepG2 cells relies on higher levels of tyrosine-phosphorylated proteins and correlates with decreased
PTP1B levels. Interestingly, Nck1 and PTP1B in cells are found in a common molecular complex and their interaction
is dependent on the SH3 domains of Nck1. Finally, Nck1 depletion in HepG2 cells neither affects PTP1B gene
transcription nor PTP1B protein stability, suggesting that Nck1 modulates PTP1B expression at the translational level.
Conclusion: Our study provides strong evidence supporting that the adaptor protein Nck1 interacts with PTP1B
and also regulates PTP1B expression. In this manner, Nck1 plays a role in regulating the PI3K/Akt pathway.
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The serine/threonine protein kinase Akt plays an essential
role in regulating various critical cellular functions, such
as cell growth, proliferation, survival and metabolism [1].
Activation of Akt involves PI3K, which converts PIP2 to
PIP3 following its interaction with receptor tyrosine ki-
nases (RTKs) or tyrosine-phosphorylated (pY) substrates
of RTKs [2]. PIP3 recruits the protein kinase PDK1
and Akt at the plasma membrane where Akt gets acti-
vated through phosphorylation within the activation
loop at Thr308 by PDK1 [3]. However, full activation of
Akt requires additional phosphorylation at Ser473 by
mTORC2 [4].
Insulin signaling is initiated by binding of insulin to
the insulin receptor (IR) tyrosine kinase, which results in
IR activation through autophosphorylation on tyrosine
residues and then tyrosine phosphorylation of insulin* Correspondence: louise.larose@mcgill.ca
Department of Medicine, Polypeptide Laboratory, McGill University and The
Research Institute of McGill University Health Centre, Montreal, QC, Canada
© 2014 Li et al.; licensee BioMed Central Ltd. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.receptor substrates (IRSs) such as IRS-1. This leads to
activation of the PI3K/Akt pathway via binding of p85,
the regulatory subunit of PI3K, to IRS-1 [5]. Numerous
studies have demonstrated that impaired insulin signaling
is closely associated with insulin resistance concomitant
with obesity and type 2 diabetes [6,7]. PTP1B, the proto-
type of non-receptor tyrosine phosphatase superfamily,
has been demonstrated to negatively regulate insulin sig-
naling using whole-body or tissue-specific PTP1B knock-
out mice [8-12]. At the molecular level, PTP1B counteracts
both IR and IRS-1 tyrosine phosphorylation to inhibit insu-
lin signaling [13,14].
In mammals, the Src homology (SH) domain-containing
adaptor protein Nck (non-catalytic region of tyrosine kin-
ase) includes two highly identical members, Nck1 and
Nck2, which contain exclusively three SH3 domains at the
N-terminus and one SH2 domain at the C-terminus [15].
Originally, Nck was associated with actin cytoplasmic
reorganization through coupling RTKs or RTK substrates
to downstream effectors regulating cytoskeleton dynamicshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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regulating translation through its interaction with the
β subunit of the eukaryotic initiation factor 2 [17] and
more recently, it was shown that Nck1 functions in cap
homeostasis by assembling the cytoplasmic capping com-
plex [18]. Furthermore, in agreement with its localization
at the endoplasmic reticulum (ER) network [19], we
demonstrated that Nck1 is also involved in regulating
the unfolded protein response (UPR) [19-22], a signal-
ing network initiated to cope with stress induced by ac-
cumulation of unfolded or misfolded proteins in the ER
[23]. Supporting this, we reported that diet-induced
obese Nck1−/− mice display improved overall glucose
homeostasis and enhanced hepatic insulin signaling that
correlates with reduced UPR compared to obese Nck1+/+
littermates [24]. Using the human hepatocellular carcin-
oma cell line HepG2, we also showed that Nck1 depletion
by siRNA promotes insulin signaling, as represented by
increased levels of pY IRS-1, Akt phosphorylation on
Ser473, GSK3β phosphorylation on Ser9 and glycogen
synthesis in response to insulin [24].
In the present study, we investigate the mechanism by
which Nck1 depletion regulates hepatic insulin signaling.
Interestingly, we found that in addition to promoting in-
sulin signaling, Nck1 depletion by siRNA in HepG2 cells
also enhances basal and other growth factor-induced
Akt phosphorylation, which correlates with increased
global pY protein levels and decreased PTP1B levels. In
addition, we demonstrated that Nck1 interacts with
PTP1B through its SH3 domains, and modulates PTP1B
protein expression likely at the translational level. Over-
all, we uncover a role for Nck1 in regulating activation
of the PI3K/Akt pathway through a PTP1B-dependent
mechanism.
Results
Nck1 depletion enhances hepatic Akt phosphorylation
and downstream signaling
Previously, we reported a role for Nck1 in regulating
hepatic insulin signaling both in vivo and in vitro [24].
In fact, in liver of obese Nck1−/− mice and in HepG2 cells
depleted of Nck1 by siRNA, we observed increased Akt
phosphorylation on Ser473 in response to insulin com-
pared to controls. Here, we showed that transient trans-
fection of HepG2 cells with Nck1 siRNA, which resulted
in more than 90% reduction in Nck1 protein levels, led to
enhanced insulin-induced Akt phosphorylation on the
activation site Thr308 (Figure 1A). To confirm a role for
Nck1 in regulating insulin-induced Akt activation in a
more physiological setting, primary hepatocytes isolated
from normal chow diet (NCD)-fed Nck1+/+ and Nck1−/−
mice were stimulated or not with insulin and total cell ly-
sates assessed for Akt phosphorylation by immunoblot.
Interestingly, primary hepatocytes from Nck1−/− mice alsodisplayed increased insulin-induced Akt phosphorylation
on Ser473 and Thr308 compared to Nck1+/+ hepatocytes
(Figures 1B and C). Although this might be attributed to
higher Akt levels in Nck1−/− hepatocytes (Figure 1D), the
absolute levels of phosphorylated Akt (pAkt), the bona
fide signaling molecule, were significantly increased in
Nck1−/− hepatocytes upon insulin stimulation, as shown
by higher pAkt Ser473/β-Actin ratio compared to Nck1+/+
hepatocytes (Figure 1E). Together, these data demon-
strate that Nck1 is a regulator of insulin-induced Akt
phosphorylation.
The transcription factor forkhead box O1 (FoxO1) is
known to translocate from the nucleus to the cytosol
upon phosphorylation by Akt [25]. To test whether signal-
ing downstream of Akt is upregulated in Nck1-depleted
HepG2 cells, we assessed FoxO1 subcellular distribution
by immunofluorescence and confocal microscopy. In
serum-starved control HepG2 cells, FoxO1 accumulated
in the nucleus, whereas nuclear FoxO1 was hardly seen in
Nck1-depleted HepG2 cells (Figure 1F), supporting dy-
namic Akt downstream signaling in these cells. Since
phosphorylation of FoxO1 by Akt is well known to limit
hepatic glucose production through decreasing transcrip-
tion of the glucose 6-phosphatase gene [26], we then com-
pared the ability of insulin to inhibit glucose production in
HepG2 cells transfected with control or Nck1 siRNA. In
accordance with increased Akt activation and cytoplasmic
localization of FoxO1, we found that Nck1-depleted HepG2
cells also displayed higher sensitivity toward the inhibitory
effect of insulin on glucose production (Figure 1G).
To delineate the mechanism by which Nck1 regulates
hepatic Akt phosphorylation, we determined whether
Nck1 depletion promotes Akt phosphorylation in re-
sponse to other growth factors. For this, we compared epi-
dermal growth factor (EGF)- and platelet-derived growth
factor (PDGF)-induced Akt phosphorylation in HepG2
cells depleted or not of Nck1. In cells transfected with
control siRNA, EGF induced Akt phosphorylation on both
Ser473 and Thr308 at 10 nM, while 1 nM of EGF dramatic-
ally enhanced Akt phosphorylation on both sites only in
Nck1-depleted cells (Figure 2A). Enhanced Akt phosphor-
ylation was also observed in Nck1-depleted cells treated
with PDGF (Figure 2B). Interestingly, we constantly ob-
served increased basal Akt phosphorylation in Nck1-
depleted cells. To further confirm the negative regulation
of Nck1 on basal Akt phosphorylation, we tested two
other siRNAs to decrease Nck1 expression in HepG2 cells.
As shown in Figure 2C, these two siRNAs, which inhibited
Nck1 expression by 62% (Nck1-1) and 94% (Nck1-2) re-
spectively, also enhanced basal Akt phosphorylation on
both Ser473 and Thr308. These findings demonstrate that
the effects of Nck1 depletion on promoting Akt phosphor-
ylation are not limited to growth factor-induced Akt phos-
phorylation, but also apply to basal Akt phosphorylation.
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Figure 1 Insulin-induced Akt phosphorylation and downstream signaling are enhanced in Nck1-depleted cells. (A) HepG2 cells transfected
with control or Nck1 siRNA were exposed to 0, 10 and 100 nM insulin for 5 min after an overnight serum starvation. Equal amount of proteins from
total cell lysates were subjected to immunoblot with indicated antibodies. (B) Primary hepatocytes isolated from Nck1+/+ and Nck1−/− mice were left
untreated or treated with 10 nM insulin for 5 min. Equal amount of proteins from total cell lysates were subjected to immunoblot with indicated
antibodies. Bar charts represent mean ± SEM of the ratio of pAkt/total Akt (C), Akt/β-Actin (D) or pAkt/β-Actin (E) quantified by densitometry analysis.
Data are representative of three independent experiments with similar results. *P <0.05 versus Nck1+/+. (F) Representative confocal images of control
or Nck1 siRNA-transfected HepG2 cells stained with FoxO1 antibody and DAPI. Images acquired at 63X magnification are representative of three
independent experiments with similar results. Scale bars equal 10 μm. (G) HepG2 cells transfected with control or Nck1 siRNA were exposed to
0, 10 and 100 nM insulin and analyzed for glucose production by measuring glucose levels in glucose-free DMEM. Glucose production was normalized
according to protein contents and expressed as relative value compared to basal. Bar chart represents mean ± SEM from six independent experiments
performed in triplicate. *P <0.05 versus siRNA control.
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ulates hepatic Akt activation.
Nck protein family includes two members sharing 68%
identity, Nck1 and Nck2. Here we showed that HepG2cells also expressed Nck2 and surprisingly, Nck1 depletion
in HepG2 cells resulted in upregulation of Nck2 expres-
sion (Figure 3A). To determine whether increased Nck2
levels contributes to the effect of Nck1 depletion on Akt
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Figure 2 EGF- and PDGF-induced Akt phosphorylation is enhanced in Nck1-depleted HepG2 cells. Overnight serum-starved HepG2 cells
transfected with control or Nck1 siRNA were exposed to 0, 1 and 10 nM EGF (A) or 0, 25 and 50 ng/ml PDGF-BB (B) for 5 min. Equal amount of
proteins from total cell lysates were subjected to immunoblot with indicated antibodies. Data are representative of three independent experiments
performed in duplicate with similar results. (C) HepG2 cells transfected with control or different Nck1 siRNAs (Nck1-1, Nck1-2) were starved overnight.
Equal amount of proteins from total cell lysates were subjected to immunoblot with indicated antibodies. Data are representative of three
independent experiments showing similar results.
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and Akt phosphorylation assessed. As shown in Figure 3B,
overexpression of Nck2 in HepG2 cells had no effect on
basal and insulin-induced phosphorylation of Akt, exclud-
ing that elevated Nck2 expression is involved in enhanced
phosphorylation of Akt in Nck1-depleted HepG2 cells. Onthe other hand, overexpression of Nck1 in HepG2 cells
also had no effect on Akt phosphorylation (Figure 3C).
This may be attributed to the fact that Nck1 is an adaptor
protein with various binding partners and its overexpression,
by perturbing Nck1 interactome homeostasis, does not es-


























Figure 3 Akt phosphorylation in HepG2 cells overexpressing Nck. (A) Total cell lysates from HepG2 cells transfected with control or Nck1
siRNA were subjected to immunoblot with indicated antibodies. Bar charts represent mean ± SEM of the ratio of Nck2/β-Actin. **P <0.01 versus
control. Total cell lysates from HepG2 cells transfected with pRK5, HA-Nck2 (B) or HA-Nck1 (C) plasmids were subjected to immunoblot with indicated
antibodies. Data are representative of three independent experiments showing similar results.
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HepG2 cells is PI3K-dependent
Given that PI3K is an upstream activator of Akt, we
assessed whether PI3K mediates the effects of Nck1 deple-
tion on basal Akt phosphorylation. HepG2 cells trans-
fected with control or Nck1 siRNA were treated with the
PI3K inhibitor LY294002 and cell lysates subjected to im-
munoblot to detect Akt phosphorylation. We found that
LY294002 completely abolished the elevated basal Akt
phosphorylation on Ser473 and Thr308 in Nck1-depleted
cells (Figure 4A), suggesting that activation of PI3K medi-
ates enhanced Akt phosphorylation in these cells. PI3K
mainly gets activated following the association of its regu-
latory subunit p85 with pY proteins, such as activated
RTKs and RTK substrates phosphorylated on tyrosineresidues [27]. Thus, we analyzed pY protein levels in con-
trol and Nck1 siRNA-transfected HepG2 cells pretreated
or not with pervanadate (PV), a general tyrosine phos-
phatase inhibitor [28]. In the absence of pervanadate,
pY protein levels were increased in Nck1-depleted cells
(Figure 4B) compared to control while PV treatment amp-
lified this difference (Figure 4C). In addition, we observed
increased levels of pY proteins associated with the p85
subunit of PI3K in Nck1-depleted cells compared to cells
transfected with control siRNA (Figure 4D). Altogether,
these data indicate that Nck1 depletion promotes PI3K-
dependent Akt phosphorylation in HepG2 cells. Further-
more, this correlates with increased levels of pY proteins
and pY proteins associated with p85, suggesting that Nck1


































Figure 4 Enhanced basal Akt phosphorylation in HepG2 cells depleted of Nck1 is dependent on PI3K, and correlates with increased
total and p85-associated pY proteins. Overnight serum-starved HepG2 cells transfected with control or Nck1 siRNA were exposed to 10 μM of
the PI3K inhibitor LY294002 for 30 min (A), untreated (B) or pretreated with 100 μM of pervanadate (PV) for 5 min (C) before harvesting. Equal
amount of proteins from total cell lysates were subjected to immunoblot with indicated antibodies. Data are representative of three independent
experiments performed in duplicate or triplicate and showing similar results. Total cell lysates prepared from HepG2 cells transiently transfected
with control or Nck1 siRNA were subjected to anti-p85 (regulatory subunit of PI3K) immunoprecipitation followed by immunoblot using indicated
antibodies (D). Data are representative of three independent experiments showing similar results.
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PTP1B is known to negatively regulate RTK signaling
that leads to activation of the PI3K/Akt pathway. Inter-
action between PTP61F and Dock, the orthologue of
PTP1B and Nck in Drosophila melanogaster, was dem-
onstrated using the yeast two-hybrid system and then
confirmed by in vitro binding assays [29]. In this study,
we assessed Nck1/PTP1B interaction in mammalian
cells. First, we used HEK293 cells transiently over-
expressing HA-Nck1 and FLAG-PTP1B given thatcompared to HepG2 cells, HEK293 cells can be trans-
fected at higher efficiency. As shown in Figure 5A, in
HEK293 cells overexpressing both Nck1 and PTP1B, we
detected PTP1B in the HA immunoprecipitates, indicating
that Nck1 and PTP1B exist in a common complex when
overexpressed. Next, we showed that endogenous Nck
coimmunoprecitated with FLAG-PTP1B transiently over-
expressed in HEK293 cells (Figure 5B). Finally, in both
HEK293 and HepG2 cells, we provided evidence that Nck
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Figure 5 Nck and PTP1B interaction. (A) HEK293 cells were transfected with FLAG-PTP1B and pRK5 (empty vector) or HA-Nck1. Total cell lysates
were subjected to anti-HA immunoprecipitation followed by immunoblot using indicated antibodies. Data are representative of three independent
experiments showing similar results. (B) HEK293 cells were transfected with FLAG-PTP1B and pcDNA3.1 (empty vector). Total cell lysates were subjected
to anti-FLAG immunoprecipitation followed by immunoblot using indicated antibodies. (C) Total cell lysates from HEK293 or HepG2 cells were
subjected to IgG or Nck immunoprecipitation followed by immunoblot with indicated antibodies. The vertical line in the immunoblot is to
indicate that samples are separated by empty lanes. (D) Cell lysates from HEK293 cells overexpressing FLAG-PTP1B were incubated with GST,
GST-Nck1, GST-SH2 domain of Nck1, GST-SH3 domains of Nck1 for 3 h followed by immunoblot with anti-FLAG antibody. Ponceau staining
reveals the GST-fusion proteins. Data are representative of three independent experiments showing similar results.
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ates its interaction with PTP1B, we performed in vitro
binding assays using bacterial recombinant GST fusion
proteins of Nck1 full-length, SH2 or SH3 domains.
Lysates prepared from HEK293 cells overexpressing
FLAG-PTP1B were incubated with the above GST fu-
sion proteins. As a result, full-length Nck1 and the SH3
domains bind to PTP1B, while the SH2 domain failed to
do so (Figure 5D). Overall, these data demonstrate that
Nck1 interacts with PTP1B through its SH3 domains in
mammalian cells.
PTP1B expression is downregulated in Nck1-depleted
HepG2 cells
Given that Nck1 interacts with PTP1B, we hypothesized
that Nck1 regulates activation of the PI3K/Akt pathway
through PTP1B. To test this, we determined PTP1B
levels in HepG2 cells transfected with control or Nck1Figure 6 Nck1 depletion downregulates PTP1B protein expression. He
and 72 h (A) or 48 h (B). Equal amount of proteins from total cell lysates w
representative of three independent experiments showing similar results. (C
subjected to immunoblot with indicated antibodies. Data represent sample
long exposure.siRNA. As shown in Figure 6A, PTP1B levels were de-
creased in HepG2 cells depleted of Nck1. This was con-
firmed using two other Nck1 siRNAs (Figure 6B). Of
note, downregulation of PTP1B levels seemed to correlate
well with the extent of Nck1 knockdown. Interestingly,
PTP1B levels were robustly decreased in liver of NCD-
fed Nck1−/− mice compared with Nck1+/+ littermates
(Figure 6C), strongly supporting our in vitro observation.
Overall, these data suggest that reduced PTP1B levels
contribute to promote activation of the PI3K/Akt pathway
in Nck1-depleted cells. Supporting this, we found that
Akt phosphorylation was increased in PTP1B−/− MEFs
(Figure 7A). In accordance, total pY protein levels were
increased in PTP1B−/− compared to PTP1B+/+ MEFs, and
this difference was even more pronounced in PV-treated
cells (Figure 7B). Interestingly, in Nck1 siRNA-transfected
HepG2 cells, reintroducing expression of Nck1 by over-
expressing a siRNA-resistant form of Nck1 preventedpG2 cells transfected with control or Nck1 siRNA were harvested at 48
ere subjected to immunoblot with indicated antibodies. Data are
) Liver extracts prepared from Nck1+/+ and Nck1−/− mice were
s of four mice under each genotype. SE: short exposure; LE:
pY
PTP1B+/+ PTP1B-/-
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Figure 7 Genetic deletion of PTP1B mimics the effects of depleting Nck1 on Akt phosphorylation and pY protein levels. (A) Total cell
lysates prepared from PTP1B+/+ and PTP1B−/− MEFs were subjected to immunoblot with indicated antibodies. Data are representative of three
independent experiments showing similar results. (B) PTP1B+/+ and PTP1B−/− MEFs were treated with or without 100 μM of PV for 5 min before
harvesting. Total cell lysates were subjected to immunoblot with indicated antibodies. Data are representative of three independent experiments
performed in triplicate and showing similar results.
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levels (Figure 8). Collectively, these results strongly sug-
gest that Nck1 regulates activation of the PI3K/Akt path-
way through a PTP1B-dependent mechanism.
To investigate the mechanism by which Nck1 deple-
tion decreases PTP1B protein expression, we then
compared PTP1B mRNA levels by quantitative real-
time PCR (qRT-PCR) on total RNA extracts prepared
from HepG2 cells transfected with control or Nck1
siRNA. As shown in Figures 9A, qRT-PCR analyses
demonstrated that depletion of Nck1 did not signifi-
cantly reduce PTP1B mRNA levels. This result was con-
firmed using liver extracts from Nck1+/+ and Nck1−/−
mice (Figure 9B). Therefore, altered PTP1B gene tran-
scription is not involved in reducing PTP1B protein
expression in Nck1-depleted HepG2 cells and liver of
Nck1−/− mice.Previously, it was shown that Akt phosphorylates
PTP1B on Ser50 and impairs its ability to dephos-
phorylate the IR [30]. To ensure that increased Akt
activation does not affect PTP1B expression in
Nck1-depleted cells, HepG2 cells transfected with
control or Nck1 siRNA were treated with the PI3K
inhibitor LY294002 or specific Akt inhibitor Akti 1/2
to block Akt activity and cell lysates subjected to
immunoblot to detect PTP1B expression. Inhibiting
PI3K or Akt did not restore PTP1B expression in
Nck1-depleted cells (Figure 9C), suggesting that de-
creased PTP1B levels in the absence of Nck1 is inde-
pendent of activation of the PI3K/Akt pathway.
Next, we examined whether depleting Nck1 in HepG2
cells alters PTP1B protein stability. Using cycloheximide,
a compound that blocks translation elongation [31], we
found that PTP1B protein turnover rate remained the
Figure 8 Reexpression of Nck1 in Nck1-depleted HepG2 cells
restores Akt phosphorylation and PTP1B expression. HepG2
cells expressing pCDNA3.1 or siRNA resistant HA-Nck1 (HA-Nck1 Res)
were further subjected to control or siRNA Nck1 transfection. Forty-eight
hours after siRNA transfection cells were exposed to 0 and 10 nM insulin
for 5 min following an overnight serum starvation. Total cell lysates were
subjected to immunoblot with indicated antibodies. The vertical
line in the immunoblot is to indicate that samples are separated by
extra lanes. Data are representative of three independent experiments
showing similar results.
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protein degradation is not involved in PTP1B downregula-
tion induced by Nck1 depletion. Indeed, neither blocking
proteasome-dependent protein degradation by MG132
nor blocking lysosome-dependent protein degradation by
chloroquine restored PTP1B expression in Nck1-depleted
cells (Figures 9E and F), confirming that reduced PTP1B
expression in Nck1-depleted cells is not due to protein
degradation. Overall, these data suggest that Nck1 regu-
lates PTP1B protein expression at the translational level.
Discussion
Previously, we reported that the whole-body Nck1
knockout improves overall glucose homeostasis in
obese mice, in agreement with enhanced hepatic insu-
lin signaling [24]. Besides, we uncovered that siRNA-
mediated Nck1 depletion in HepG2 cells also enhances
insulin signaling. These data strongly suggest that
Nck1 is a regulator of hepatic insulin signaling. How-
ever, the mechanism by which Nck1 depletion regu-
lates hepatic insulin signaling remains to be elucidated.
In the present study, we report that in addition to
insulin-induced Akt phosphorylation, Nck1 depletion
also impacts Akt phosphorylation in serum-starved
(basal) HepG2 cells and in response to other growth
factors such as EGF and PDGF. Furthermore, wedemonstrate that elevated Akt phosphorylation in
Nck1-depleted HepG2 cells correlates with higher
levels of total pY proteins and pY proteins associated
with the p85 subunit of PI3K. Meanwhile, we find
that Nck1 interacts with PTP1B and regulates its
protein expression. Taken together, these data let us
propose that Nck1 depletion, by reducing PTP1B ex-
pression, enhances tyrosine-phosphorylated proteins
that trigger PI3K activation, therefore promoting Akt
phosphorylation.
PTP1B is a negative regulator of insulin signaling
by dephosphorylating IR and IRS proteins [13,32]. In
accordance, whole-body PTP1B knockout mice are
hypersensitive to insulin and resistant to high fat
diet (HFD)-induced insulin resistance [8,9]. In cul-
tured primary human skeletal muscle, manipulating
PTP1B expression levels inversely modulates insulin-
induced Akt phosphorylation, and increased PTP1B
expression in skeletal muscle of patients with type 2
diabetes is associated with decreased whole-body in-
sulin sensitivity [33]. Moreover, PTP1B−/− MEFs dis-
play marked increase in tyrosine-phosphorylated
EGFR [34] and PDGFR [34,35]. In this study, we ob-
serve lower PTP1B levels in HepG2 cells depleted of
Nck1, which we believe contribute to promote pro-
tein tyrosine phosphorylation and activation of the
PI3K/Akt pathway, as supported by elevated basal
pY protein levels and Akt phosphorylation in MEFs
lacking PTP1B. However, the underlying PTP1B sub-
strate(s) that regulates Akt phosphorylation in Nck1-
depleted cells remain to be determined, although IR,
IRS, EGFR and PDGFR are all well-known targets of
PTP1B. Considering the localization of PTP1B at the
cytoplasmic face of the ER [36], reduced PTP1B
levels in Nck1-depleted cells might induce activation
of the PI3K/Akt pathway in a ligand-independent
manner by promoting phosphorylation of newly syn-
thesized RTKs during their processing, as reported
for the insulin receptor precursors at the ER [37].
Localized at the ER, PTP1B has been involved in
the regulation of the UPR initiated upon ER stress
[38-40]. Interestingly, we previously demonstrated
that Nck1 also localizes at the ER and regulates
the UPR [19-22,24]. The UPR is mainly composed
of three arms triggered by distinct ER transmem-
brane proteins: inositol-requiring enzyme 1α (IRE1α),
protein kinase R-like ER kinase (PERK) and activat-
ing transcription factor 6 (ATF6) [23]. Recently,
obesity-induced insulin resistance in peripheral
insulin target tissues has been linked to ER stress
that results in abnormal activation of the UPR
[41-43]. In fact, obesity leads to sustained activation
of IRE1α that impairs insulin signaling through
IRE1α/JNK-mediated phosphorylation of IRS-1 that
CD
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Figure 9 Nck1 depletion affects neither PTP1B gene transcription nor protein stability. (A) Quantitative RT-PCR analysis of PTP1B mRNA
levels in HepG2 cells transfected with control or Nck1 siRNA. Data are presented as mean ± SEM from five independent experiments. The expression
levels of PTP1B mRNA in control siRNA-transfected cells were set to one. (B) Quantitative RT-PCR analysis of PTP1B mRNA levels in liver of Nck1+/+ and
Nck1−/− mice. Data are presented as mean ± SEM of four mice under each genotype. The expression levels of PTP1B mRNA in Nck1+/+ mice were set
to one. (C) HepG2 cells transfected with control or Nck1 siRNA were treated with 10 μM of the PI3K inhibitor LY294002 or 10 μM of the Akt inhibitor
Akti 1/2 for 24 h before harvesting. Equal amount of proteins from total cell lysates were subjected to immunoblot with indicated antibodies. Data are
representative of three independent experiments performed in duplicate and showing similar results. (D) Twelve hours after transfection, HepG2 cells
transfected with control or Nck1 siRNA were treated with 100 μg/ml of cycloheximide (CHX) for additional 12, 24 or 36 h. Equal amount of proteins
from total cell lysates were subjected to immunoblot with indicated antibodies. The graph represents PTP1B levels at different times of CHX exposure
as mean ± SEM from three independent experiments with PTP1B levels at time 0 in control and Nck1 siRNA-transfected cells fixed to one. (E) HepG2
cells transfected with control or Nck1 siRNA were treated with 0, 10, 25, 50 and 100 μM MG132 for 6 h. Equal amount of proteins from total cell lysates
were subjected to immunoblot with indicated antibodies. Data are representative of three independent experiments showing similar results. (F) HepG2
cells transfected with control or Nck1 siRNA were treated with 100 μM chloroquine (CQ) for 12 or 24 h. Equal amount of proteins from total cell lysates
were subjected to immunoblot with indicated antibodies. Data are representative of three independent experiments showing similar results.
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IR [42]. Whole-body Nck1 knockout mice are resist-
ant to HFD-induced insulin resistance and ER stress,
resembling the phenotype of liver-specific PTP1B
knockout mice [11,24,44]. Given that Nck1 interacts
with PTP1B and modulates PTP1B protein expres-
sion as we demonstrate here, it is plausible that the
protective effect of Nck1 deficiency against HFD-
induced insulin resistance and ER stress could be attrib-
uted to PTP1B downregulation in liver of Nck1−/− mice.
The interaction between PTP1B and Nck was first
reported in Drosophila melanogaster, and suggested to
involve the SH3 domains of Dock, the Nck orthologue
[29,45,46]. This is consistent with the fact that the C-
terminus of PTP1B harbors two proline-rich sequences
that match the consensus SH3 domain-binding motif
[47,48]. In mammalian cells, Nck1 associates with PTP1B
independent of insulin stimulation, suggesting a SH3-
mediated interaction as well [49]. In this study, we provide
clear evidence showing that Nck1 interacts with PTP1B
through its SH3 domains. Further experiments are re-
quired to characterize which SH3 domain(s) is responsible
for this interaction.
In the current study, we demonstrate that PTP1B pro-
tein levels are drastically decreased in Nck1-depleted
HepG2 cells and liver of Nck1−/− mice. Interestingly, a re-
cent study reports that PTP1B−/− mice fed a NCD or HFD,
both display significantly lower levels of Nck1 in skeletal
muscle, although the underlying mechanism has not been
investigated [50]. Therefore, a reciprocal regulation be-
tween Nck1 and PTP1B may exist. Our findings suggest
that Nck1 modulates PTP1B expression at the translational
level. In fact, qRT-PCR analysis reveals no change of
PTP1B gene transcription in HepG2 cells depleted of Nck1
or in Nck1−/− liver. Using the proteasome inhibitor MG132
or lysosome inhibitor chloroquine, we rule out an effect of
Nck1 depletion on PTP1B protein degradation. Further-
more, PTP1B is known to be cleaved at the C-terminal
ER-targeting domain by the cysteine protease calpain, re-
leasing a 42 kDa soluble form of PTP1B in the cytosol
[51]. Decrease in PTP1B protein levels in Nck1-depleted
cells is not attributed to the C-terminal cleavage of PTP1B,
since the anti-PTP1B antibody used in this study is raised
against its N-terminus, therefore would detect the cleaved
form of PTP1B. Taken together, it is then possible that
Nck1 affects PTP1B mRNA translation. In agreement with
our previous observation that Nck1 modulates protein
translation [20], we observed a decrease in general protein
synthesis in HepG2 cells depleted of Nck1 as measured by
35S-Met/Cyst incorporation (unpublished data). However,
given that numerous protein levels (e.g. Akt, β-actin,
HSP90), as determined by immunoblot, are not affected in
the Nck1-depleted HepG2 cells, Nck1 might play an essen-
tial role in maintaining proper translation of specificmRNAs such as PTP1B mRNA. Considering the essential
role of Nck1 in assembling the cytoplasmic capping com-
plex [18], it is plausible that depletion of Nck1 results in ac-
cumulation of uncapped PTP1B transcripts that are not
efficiently translated. Further investigation is required to
test this hypothesis. Alternatively, microRNAs, by binding
to their target mRNAs, act as posttranscriptional regula-
tors to repress target mRNA translation [52]. Searching
TargetScan database reveals several putative microRNA
binding sites on the 3’-UTR of human PTP1B mRNA,
including miR-1, miR-206, miR-613, miR-124, miR-506,
etc. Interestingly, IRE1α branch of the UPR is involved
in decreasing microRNA expression either through the
IRE1α endoribonuclease activity [53-55] or in a JNK-
dependent manner [56]. Considering that Nck1 depletion
attenuates IRE1α/JNK signaling [24], further experiments
will be performed to determine whether Nck1 depletion
affects PTP1B protein expression by indirectly increasing
microRNAs that target PTP1B mRNA.
Conclusions
Our study highlights the implication of PTP1B in mediating
Nck1-dependent regulation of the hepatic PI3K/Akt path-
way. Since Akt is a critical node in regulating insulin and
growth factor biological actions, our findings contribute to
identify Nck1 as a potential target in therapeutic strategies
for insulin resistance and cancer. Furthermore, the striking
effects of PTP1B on metabolic diseases and cancer in pre-
clinical research make it an attractive drug target. However,
the development of PTP1B inhibitors is halted by selectivity
and bioavailability of these drugs [57,58]. Given the ability
of Nck1 to regulate PTP1B expression, Nck1 could be a
substitutive target to bypass the bottleneck of developing
PTP1B inhibitors.
Methods
Cell culture and treatments
Human hepatocellular carcinoma cells (HepG2) were
grown in minimum essential Eagle’s medium (MEM;
GIBCO) containing 10% fetal bovine serum (FBS; GIBCO)
and 1% antibiotic-antimycotic (anti-anti) solution, which
contains 10,000U/ml of penicillin, 10,000 μg/ml of
streptomycin, and 25 μg/ml of Fungizone® (GIBCO).
Human embryonic kidney (HEK) 293 cells, PTP1B wild
type (PTP1B+/+) and knockout (PTP1B−/−) mouse embry-
onic fibroblasts (MEFs) were grown in Dulbecco's modified
Eagle’s medium (DMEM; GIBCO) containing 10% FBS
and 1% anti-anti. Cells were incubated at 37°C in a 5%
CO2 environment. Small interference (si) RNAs against
human Nck1 (Nck1) 5’-AACAUCCAUUACAUCUCCUU
UCUCGAA-3’, (Nck1-1) 5’-GGAGAUGUAAUGGAU GU
UA-3’ , (Nck1-2) 5’-GGCCUUCACUCACUGGAAA-3’
were purchased from Integrated DNA Technologies.
Scramble siRNA purchased from Ambion was used as
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Lipofectamine RNAiMAX reagent (Invitrogen) according
to the manufacturer’s instructions, with a final siRNA con-
centration of 40 nM. HA-Nck1 and HA-Nck2 overexpres-
sion in HepG2 cells were performed using Lipofectamine
2000 according to the manufacturer’s instructions. Re-
expression of siRNA resistant HA-Nck1 in Nck1 siRNA-
transfected HepG2 cells using Lipofectamine 3000 was
performed 24 h prior siRNA transfection according to the
manufacturer’s instructions. HEK293 cells were transfected
with empty vector, HA-Nck1 and/or FLAG-rat PTP1B
using CalPhos™ mammalian transfection kit (Clontech) ac-
cording to the manufacturer’s instructions. HepG2 cells
were starved overnight in MEM containing 0.1% bovine
serum albumin (BSA, Invitrogen) after 48 h siRNA trans-
fection, and then incubated with either insulin (Eli Lilly Co.,
Indianapolis, IN), EGF (Fitzgerald Industries International),
PDGF-BB (Roche), pervanadate (Sgima), LY294002
(Calbiochem) or Akt inhibitor 1/2 (Calbiochem) at con-
centrations indicated in Figure legends. Cycloheximide
(Calbiochem), MG132 (Calbiochem) or chloroquine
diphosphate salt (Sigma) were added to HepG2 cells
after siRNA transfection without starvation at concen-
trations indicated in Figure legends.
Mice
Nck1+/− mice were previously obtained from Dr. Tony
Pawson (Toronto, Canada) [59] and used to generate
Nck1+/+ and Nck1−/− littermates. Mice were maintained
in an animal facility with fixed 12 h light/dark cycle and
free access to water and food. All animal care and hand-
ling followed the guidelines of McGill University (proto-
col #5069) according to the standards defined by the
Canadian Council on Animal Care. Only male mice were
used in this study.
Liver extracts and isolated primary hepatocytes
Age-matched mice were used to harvest liver or prepare
primary hepatocytes. Mice were euthanized using a CO2
chamber, tissues immediately collected, snap-frozen in
liquid nitrogen, and kept at −80°C for further processing.
To prepare tissue extracts, tissues were homogenized
using a Polytron at 20% (w/v) in 5 mM Tris · HCl
(pH 7.4), 0.25 M sucrose, 1 mM MgCl2, 1 mM dithio-
threitol, 10 mM sodium pyrophosphate, 1 mM sodium
orthovanadate, 100 mM sodium fluoride, and 17.5 mM
β-glycerophosphate supplemented with protease inhibi-
tors. Triton X-100 was added to a final concentration of
1%. Following 10 min incubation at 4°C, samples were
centrifuged at 13,000 g for 10 min at 4°C. Supernatants
were further centrifuged at 200,000 g for 30 min at 4°C.
Final supernatants were subjected to Bio-Rad protein
assay (Bio-Rad) for protein quantification and equal
amount of protein was used for immunoblot analysis.Mouse primary hepatocytes were isolated according to
Renton et al. [60] with minor modifications. Briefly, anes-
thetized mice were subjected to in situ liver perfusion via
a cannula inserted in the inferior vena cava through the
heart’s right atrium, while the portal vein was cut. Then,
liver was first perfused with heparin solution (10 mM
HEPES (pH 7.85), 142 mM NaCl, 6.7 mM KCl, 0.6 mM
EGTA and 1.5 U/ml Heparin), followed by collagenase
solution (10 mM HEPES (pH 7.85), 142 mM NaCl,
6.7 mM KCl, 12 mM CaCl2 · 2H2O and 200 U/ml colla-
genase). Perfused liver was transferred to a petri dish,
gently teased apart with forceps, filtered through two
layers of gauze, washed twice with MEM containing
10% FBS and antibiotics, and then plated in 6-well
plates coated with collagen matrix (Vitrogen-100; Collagen
Corp.). Primary hepatocytes were cultured as previously
reported [61]. Insulin stimulation, carried out in serum-
free media, was evaluated two days after initial plating fol-
lowing the conditions indicated in the Figure legends.
Antibodies
As previously described, rabbit polyclonal anti-Nck1
antibody was generated using GST-fusion protein encod-
ing human Nck1-specific amino acid sequences between
the third SH3 and the SH2 domains (Nck1: QNNPL-
TSGLEPSPPQCDYIRPSLTGKFAGNP) [24]. Rabbit poly-
clonal anti-p85 antibody was generated using GST-fusion
protein encoding the two SH2 domains of the p85 subunit
of PI3K. pAkt (Ser473 and Thr308), Akt, FoxO1, β-Actin
and HSP90 antibodies were purchased from Cell Signaling
Technology. pY20 antibody was purchased from Santa
Cruz Biotechnology, PTP1B antibody from BD Biosciences,
anti-HA matrix from Roche, while FLAG antibodies was
from Sigma.
Cell lysates, immunoblot and immunoprecipitation
Cells were washed twice with ice-cold phosphate-buffered
saline (PBS) and detergent-soluble proteins were extracted
using lysis buffer (50 mM HEPES (pH 7.5), 150 mM NaCl,
10% glycerol, 1% Triton X-100, 1.5 mM MgCl2, 1 mM
EGTA, 10 mM sodium pyrophosphate, 100 mM sodium
fluoride) supplemented with protease inhibitors. Following
centrifugation at 13,300 g for 10 min at 4°C, supernatants
were subjected to Bio-Rad protein assay. Total cell lysates
normalized for protein were resolved by SDS-PAGE,
transferred onto nitrocellulose membrane, and immuno-
blotted with indicated antibodies. Enhanced chemilumin-
escence (Amersham GE Healthcare) was used to detect
immunoreactive proteins according to the manufacturer’s
instructions. For p85 immunoprecipitation, total cell ly-
sates prepared from HepG2 cells were incubated with
anti-p85 antibody overnight at 4°C. The next day, protein
A-agarose (Santa Cruz Biotechnology) was added to the
lysate-antibody mixture and samples were further incubated
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total cell lysates were incubated with either anti-HA, anti-
FLAG or anti-Nck antibodies for 2 h or overnight at 4°C.
Immunoprecipitated proteins were washed three times
with lysis buffer, resuspended in Laemmli buffer, heated
at 95°C for 5 min and freezed until analysis by immuno-
blot as described above.
Glucose production
HepG2 cells transfected with control or Nck1 siRNA were
plated in 12-well plates. After an overnight serum starva-
tion, cells were incubated with insulin for 6 h. Then, media
were replaced by 0.4 ml/well of phenol red-free, glucose-
free DMEM containing 2 mM sodium pyruvate (GIBCO)
and 20 mM lactate (Sigma) in the presence of insulin for
another 3 h. Finally, these media were collected and sub-
jected to glucose measurement by the Amplex® Red glu-
cose/glucose oxidase assay kit (Invitrogen). Glucose levels
were normalized according to protein contents.
GST pull-down assay
GST, GST-Nck1 full length, GST-Nck1 SH2 domain and
GST-Nck1 SH3 domain proteins induced in bacteria ac-
cording to classical procedures and purified using gluta-
thione agarose beads were mixed with total cell lysates
from HEK293 cells overexpressing FLAG-PTP1B for 3 h
at 4°C. Following the incubation, beads were washed with
lysis buffer. Proteins were recovered in Laemmli buffer
and analyzed by immunoblot.
Immunofluorescence and confocal microscopy
HepG2 cells were plated on coverslips in 6-well plates
and transfected with control or Nck1 siRNA. After an
overnight serum starvation, cells were fixed in 4% parafor-
maldehyde for 15 min. Fixed cells were blocked in PBS
containing 5% donkey serum and 0.3% Triton X-100 for
1 h followed by an overnight incubation with anti-FoxO1
antibody at 4°C. The next day, cells were incubated
with Alexa Fluor® 488 donkey anti-rabbit IgG (H + L)
(Invitrogen) for 1 h at room temperature followed by
the nuclear staining with 4’, 6-diamidino-2-phenylin-
dole dihydrochloride (DAPI, Sigma). Coverslips were
mounted on glass slides using ProLong® Gold antifade re-
agent (Invitrogen). Images were captured using a Zeiss
LSM 510 confocal microscope.
RNA extraction and quantitative real-time PCR
Total RNA was extracted from transfected HepG2 cells
or liver of Nck1+/+ and Nck1−/− mice using TRIzol reagent
(Invitrogen) according to the manufacturer’s instructions.
RNA was reverse transcribed to cDNA using High
Capacity cDNA Reverse Transcription Kit (Life Tech-
nologies™). Human PTP1B gene in HepG2 cells was
amplified using Taqman® Fast Advanced Master Mix(Life Technologies™) in the ViiA™ 7 Real-Time PCR
system (Life Technologies™), while mouse PTP1B gene
in liver extracts was amplified using Power SYBR®
Green PCR Master Mix (Life Technologies™). Primer
sequences used for mouse PTP1B gene were: forward
5’-TGGCCACAGCAAGAAGAAAA-3’ and reverse 5’-
GGAAATGCAGGATCTCTCGA-3’. GAPDH and cyclo-
philin were used as internal control.
Statistical analyses
Quantification of immunoreactive signal was performed
using the analysis software Quantity One (Bio-Rad) on a
GS-800 Calibrated Densitometer (BIO-RAD). Results are
presented as means ± SEM. Student’s t-test statistical ana-
lyses (unpaired) were performed using SigmaPlot Version
12 (Systat Software Inc.). P value <0.05 was considered to
be statistically significant.
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